The most frequently reported adverse events to trimetazidine are dizziness, headache, abdominal pain, diarrhea, dyspepsia, nausea and vomiting, rash, pruritus, urticaria, and asthenia.
Blood and lymphatic system: Agranulocytosis, thrombocytopenia, thrombocytopenic purpura.
Nervous system disorders: Parkinsonian symptoms (tremor, akinesia, hypertonia), gait instability, restless leg syndrome, other movement-related disorders, sleep disorders (insomnia, drowsiness).
Cardiac disorders: Palpitations, extrasystoles, tachycardia.
Vascular disorders: Arterial hypotension, orthostatic hypotension, flushing.
Gastrointestinal disorders: Constipation.
Hepatobiliary disorders: Hepatitis.
Skin and subcutaneous tissue disorders: Acute generalized exanthematous pustulosis (AGEP), angioedema.